R Martín-Vivaldi

530 total citations
19 papers, 372 citations indexed

About

R Martín-Vivaldi is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, R Martín-Vivaldi has authored 19 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hepatology, 6 papers in Surgery and 5 papers in Epidemiology. Recurrent topics in R Martín-Vivaldi's work include Drug-Induced Hepatotoxicity and Protection (4 papers), Drug Transport and Resistance Mechanisms (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). R Martín-Vivaldi is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (4 papers), Drug Transport and Resistance Mechanisms (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). R Martín-Vivaldi collaborates with scholars based in Spain and Nicaragua. R Martín-Vivaldi's co-authors include F. Nogueras, Gloria Isabel Carvajal Peláez, Raúl J. Andrade, M. Isabel Lucena, Luı́s Rodrigo, José Antonio Durán, Javier Salmerón, J.M. Navarro, Manuel Romero‐Gómez and Manuel Jesús Romero-Jiménez and has published in prestigious journals such as Gastroenterology, Hepatology and Journal of Hepatology.

In The Last Decade

R Martín-Vivaldi

18 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R Martín-Vivaldi Spain	8	192	120	102	87	74	19	372
F. Nogueras Spain	7	123 0.6×	54 0.5×	99 1.0×	66 0.8×	40 0.5×	17	268
R. Hidalgo Brazil	10	95 0.5×	130 1.1×	76 0.7×	24 0.3×	145 2.0×	21	347
Simona Rossi United States	10	92 0.5×	104 0.9×	96 0.9×	54 0.6×	58 0.8×	19	277
Priya Grewal United States	11	65 0.3×	188 1.6×	136 1.3×	101 1.2×	36 0.5×	24	423
Lay Ahyoung Lim Japan	12	39 0.2×	40 0.3×	52 0.5×	82 0.9×	78 1.1×	23	299
Rene Peleman United States	8	58 0.3×	233 1.9×	227 2.2×	36 0.4×	157 2.1×	12	499
Dev Katarey United Kingdom	6	163 0.8×	112 0.9×	149 1.5×	61 0.7×	59 0.8×	8	352
Mariola Post Poland	12	75 0.4×	81 0.7×	134 1.3×	132 1.5×	119 1.6×	26	389
Hanns Ackermann Germany	7	39 0.2×	181 1.5×	159 1.6×	151 1.7×	132 1.8×	7	411

Countries citing papers authored by R Martín-Vivaldi

Since Specialization

Citations

This map shows the geographic impact of R Martín-Vivaldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Martín-Vivaldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Martín-Vivaldi more than expected).

Fields of papers citing papers by R Martín-Vivaldi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Martín-Vivaldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Martín-Vivaldi. The network helps show where R Martín-Vivaldi may publish in the future.

Co-authorship network of co-authors of R Martín-Vivaldi

This figure shows the co-authorship network connecting the top 25 collaborators of R Martín-Vivaldi. A scholar is included among the top collaborators of R Martín-Vivaldi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Martín-Vivaldi. R Martín-Vivaldi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Otero, Alejandra, Evaristo Varó, J. Ortiz de Urbina, et al.. (2009). A prospective randomized open study in liver transplant recipients: Daclizumab, mycophenolate mofetil, and tacrolimus versus tacrolimus and steroids. Liver Transplantation. 15(11). 1542–1552. 24 indexed citations

Romero‐Gómez, Manuel, M. Diago, Raúl J. Andrade, et al.. (2008). 1001 INTERIM ANALYSIS FROM TRIC-1 A STUDY OF METFORMIN WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT NAIVE GENOTYPE 1 CHRONIC HEPATITIS C WITH INSULIN RESISTANCE. Journal of Hepatology. 48. S375–S375. 6 indexed citations

Mata, Manuel de la, Natividad Cuende, A Bernardos, et al.. (2006). Model for End-Stage Liver Disease Score-Based Allocation of Donors for Liver Transplantation: A Spanish Multicenter Experience. Transplantation. 82(11). 1429–1435. 37 indexed citations

Andrade, Raúl J., M. Isabel Lucena, M. Carmen Fernández, et al.. (2005). Drug-Induced Liver Injury: An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-Year Period. Gastroenterology. 129(2). 512–521. 66 indexed citations

Nogueras, F., et al.. (2005). Mycophenolate Mofetil–Induced Neutropenia in Liver Transplantation. Transplantation Proceedings. 37(3). 1509–1511. 27 indexed citations

Romero‐Gómez, Manuel, I. Wichmann, Javier Crespo, et al.. (2004). Serum Immunological Profile in Patients with Chronic Autoimmune Cholestasis. The American Journal of Gastroenterology. 99(11). 2150–2157. 15 indexed citations

Andrade, Raúl J., M. Isabel Lucena, Miren García‐Cortés, et al.. (2004). HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease. Hepatology. 39(6). 1603–1612. 108 indexed citations

Fernández‐Santaella, M. Carmen, Teresa Ferrer, R Martín-Vivaldi, et al.. (2001). Flutamide-induced hepatotoxicity: report of a case series.. PubMed. 93(7). 423–32. 31 indexed citations

Martín-Vivaldi, R, F. Nogueras, Joan Manuel Salmerón, et al.. (2000). Multicenter retrospective study of response to interferon in chronic hepatitis B.. PubMed. 92(9). 561–72. 1 indexed citations

10.

Andrade, Raúl J., M. Isabel Lucena, R Martín-Vivaldi, et al.. (1999). Acute liver injury associated with the use of ebrotidine, a new H 2 -receptor antagonist. Journal of Hepatology. 31(4). 641–646. 38 indexed citations

11.

Martín-Vivaldi, R, et al.. (1997). Response of chronic hepatitis C to interferon-alpha treatment and relationship with iron metabolism.. PubMed. 89(7). 523–30. 5 indexed citations

12.

Nogueras, F., et al.. (1996). [Pasteurella multocida as a cause of spontaneous bacterial peritonitis in a cirrhotic patient].. PubMed. 88(9). 644–5. 1 indexed citations

13.

Nogueras, F., et al.. (1996). [Comparison of the indexes of serologic activity with endoscopy in intestinal inflammatory disease].. PubMed. 19(7). 344–6. 1 indexed citations

14.

Suárez, José Francisco, et al.. (1996). [Intrahepatic cholestasis of pregnancy. Maternofetal implications].. PubMed. 88(11). 780–4. 3 indexed citations

15.

Martín-Vivaldi, R, et al.. (1996). [Thyroid dysfunction in patients with chronic hepatitis C pre and post treatment with interferon].. PubMed. 88(7). 480–4. 3 indexed citations

16.

Martín-Vivaldi, R, et al.. (1995). [Emergency laparoscopy. A 20-year experience].. PubMed. 87(4). 305–8. 4 indexed citations

17.

Martín-Vivaldi, R, et al.. (1994). [Caroli's syndrome: a variable entity].. PubMed. 86(5). 849–52. 1 indexed citations

18.

Nogueras, F., et al.. (1994). [The effect of environmental factors in inflammatory bowel disease].. PubMed. 86(3). 642–4. 1 indexed citations

19.

Fernández-Martı́nez, Amalia, et al.. (1980). [Ultrasonics in the diagnosis of primary and metastatic hepatic tumors].. PubMed. 158(1-2). 33–6.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact